<scp>SGLT2</scp> inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2024-11-29
DOI
https://doi.org/10.1111/dom.16097
Citations
9
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SGLT2 inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

Jesper Nørgaard Bech, Camilla Lundgreen Duus, Frank Holden Mose, Frederik Husum Mårup et al.
9 citations
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
3.22
article

SGLT2 inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

Jesper Nørgaard Bech, Camilla Lundgreen Duus, Frank Holden Mose, Frederik Husum Mårup, Niels Henrik Buus, Didde Kidmose Kristensen, Steffen Flindt Nielsen
article en
9 citations

Abstract

No abstract available for this paper.
Diabetes Obesity and MetabolismVol. 27(3)
Aarhus University (DK), Aarhus University Hospital (DK)
Augustinus Fonden
Good health and well-being
Openalex Percentile: Top 7%
Diabetes Treatment and Management
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.